The phenylethanolamines, ifenprodil and CP-101,606, are NMDA receptor antag
onists with promising neuroprotective properties. In recombinant NMDA recep
tors expressed in Xenopus oocytes, we found that these drugs inhibit NMDA r
eceptors through a unique mechanism, making the receptor more sensitive to
inhibition by protons, an endogenous negative modulator. These findings sup
port a critical role for the proton sensor in gating the NMDA receptor and
point the way to identifying a context-dependent NMDA receptor antagonist t
hat is inactive at physiological pH, but is a potent inhibitor during the a
cidic conditions that arise during epilepsy, ischemia and brain trauma.